Diona Simoneit - Nov 15, 2022 Form 4/A - Amendment Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Accounting Officer
Signature
By: Mark Hueppelsheuser For: Diona Simoneit
Stock symbol
TOI
Transactions as of
Nov 15, 2022
Transactions value $
-$385
Form type
4/A - Amendment
Date filed
11/22/2022, 07:08 PM
Date Of Original Report
Nov 17, 2022
Previous filing
Apr 5, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Sale -$385 -190 -0.64% $2.03 29.3K Nov 15, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A amends and restates the reporting persons Form 4 originally filed on November 17, 2022 in the entirety. This Form 4/A is being filed to correct the reporting persons original Form 4 from Code D to Code S. The sales reported in the Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
F2 Price is the volume weighted average selling price of all sales by the Reporting Person on November 15, 2022 within a one-dollar range. Actual prices ranged from $2.025 to $2.028. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.